Literature DB >> 19133896

Multiple genetic tests for susceptibility to smoking do not outperform simple family history.

Coral E Gartner1, Jan J Barendregt, Wayne D Hall.   

Abstract

AIMS: To evaluate the utility of using predictive genetic screening of the population for susceptibility to smoking.
METHODS: The results of meta-analyses of genetic association studies of smoking behaviour were used to create simulated data sets using Monte Carlo methods. The ability of the genetic tests to screen for smoking was assessed using receiver operator characteristic curve analysis. The result was compared to prediction using simple family history information. To identify the circumstances in which predictive genetic testing would potentially justify screening we simulated tests using larger numbers of alleles (10, 15 and 20) that varied in prevalence from 10 to 50% and in strength of association [relative risks (RRs) of 1.2-2.1].
RESULTS: A test based on the RRs and prevalence of five susceptibility alleles derived from meta-analyses of genetic association studies of smoking performed similarly to chance and no better than the prediction based on simple family history. Increasing the number of alleles from five to 20 improved the predictive ability of genetic screening only modestly when using genes with the effect sizes reported to date.
CONCLUSIONS: This panel of genetic tests would be unsuitable for population screening. This situation is unlikely to be improved upon by screening based on more genetic tests. Given the similarity with associations found for other polygenic conditions, our results also suggest that using multiple genes to screen the general population for genetic susceptibility to polygenic disorders will be of limited utility.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19133896     DOI: 10.1111/j.1360-0443.2008.02392.x

Source DB:  PubMed          Journal:  Addiction        ISSN: 0965-2140            Impact factor:   6.526


  5 in total

Review 1.  Genetic testing and common disorders in a public health framework: how to assess relevance and possibilities. Background Document to the ESHG recommendations on genetic testing and common disorders.

Authors:  Frauke Becker; Carla G van El; Dolores Ibarreta; Eleni Zika; Stuart Hogarth; Pascal Borry; Anne Cambon-Thomsen; Jean Jacques Cassiman; Gerry Evers-Kiebooms; Shirley Hodgson; A Cécile J W Janssens; Helena Kaariainen; Michael Krawczak; Ulf Kristoffersson; Jan Lubinski; Christine Patch; Victor B Penchaszadeh; Andrew Read; Wolf Rogowski; Jorge Sequeiros; Lisbeth Tranebjaerg; Irene M van Langen; Helen Wallace; Ron Zimmern; Jörg Schmidtke; Martina C Cornel
Journal:  Eur J Hum Genet       Date:  2011-04       Impact factor: 4.246

2.  Integrating genetic studies of nicotine addiction into public health practice: stakeholder views on challenges, barriers and opportunities.

Authors:  M J Dingel; A D Hicks; M E Robinson; B A Koenig
Journal:  Public Health Genomics       Date:  2011-07-09       Impact factor: 2.000

3.  Unwarranted optimism in media portrayals of genetic research on addiction overshadows critical ethical and social concerns.

Authors:  Jenny E Ostergren; Molly J Dingel; Jennifer B McCormick; Barbara A Koenig
Journal:  J Health Commun       Date:  2015-03-25

Review 4.  Polygenic susceptibility to breast cancer: current state-of-the-art.

Authors:  Maya Ghoussaini; Paul D P Pharoah
Journal:  Future Oncol       Date:  2009-06       Impact factor: 3.404

5.  On the futility of screening for genes that make you fat.

Authors:  J Lennert Veerman
Journal:  PLoS Med       Date:  2011-11-01       Impact factor: 11.069

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.